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Background:  The presence of left ventricular outflow tract obstruction (LVOTO) in patients with Hypertrophic Cardiomyopathy (HCM) is related to 
clinically relevant outcomes. In this study, we evaluate the respective and combined associations of anterior mitral valve leaflet length (AMVLL) and 
septal wall thickness (SWT) with the presence of LVOTO in a cohort of patients with HCM.
Methods:  Cardiovascular MRI and echocardiography imaging from 76 consecutive HCM and 76 control patients, defined as patients with normal 
systolic function and no evidence of mitral valve disease, were blindly analyzed (total N= 152). Cine CMR images were analyzed using commercial 
software to identify the maximal SWT in the short axis and AMVLL in the 3-chamber view. Echocardiography imaging was analyzed to identify the 
peak left ventricular outflow tract gradient. Respective associations of AMVLL and SWT to the presence of LVOTO, defined as a resting gradient ≥30 
mmHg, were explored. “Septal-wall Anterior Leaflet Product” (SALP), the product of AMVLL and SWT measurements, was also evaluated in an a-priori 
manner.
Results:  The mean age was 54.9±14.0 years. Patients with HCM demonstrated higher SWT and AMVLL values versus controls [19.4±5.5 mm vs 
10.1±2.3 mm, (p<0.0001) and 26.2±4.9 mm vs 21.1±4.0 mm (p=<0.001). In the HCM cohort both SWT and SALP were significantly associated with 
the presence of LVOTO, documented in 17 patients (22.4%). A non-significant trend towards greater AMVLL was seen in those with LVOTO (p=0.07). 
Receiver Operator Characteristics (ROC) analysis showed SALP to be the most predictive measure for the presence of LVOTO (AUC=0.81). SWT alone 
provided only a modest predictive accuracy (AUC=0.72).
Conclusion:  This study confirms that elongation of the AMVL is a phenotypic feature of HCM. The presence of LVOTO in this population appears to 
be dependent upon interplay between SWT and AMVL length. Their combined contribution, represented by SALP, shows the strongest association to 
LVOTO.
